Cresco Labs Inc. has filed a prospectus supplement dated January 29, 2026 to its October 3, 2025 short form base shelf prospectus, qualifying an at-the-market equity distribution of up to C$140,000,000 of Subordinate Voting Shares on the Canadian Securities Exchange (CSE) under symbol “CL”. Sales, if any, will be made through Haywood Securities Inc. as agent on the CSE or other Canadian marketplaces at prevailing market prices, with no minimum proceeds and no stabilization or over-allocation transactions permitted. The agent will receive a commission equal to 2.5% of the gross proceeds from Subordinate Voting Shares sold, and Cresco estimates total offering expenses (excluding agent compensation) at approximately US$250,000. Net proceeds are intended for general corporate purposes, repayment of indebtedness, discretionary capital programs and potential acquisitions, with management retaining broad discretion over actual use and potential reallocation. As of September 30, 2025, Cresco had 340,486,810 Subordinate Voting Shares outstanding, and on January 28, 2026 the CSE closing price was C$1.47 per share. The base shelf prospectus also notes that on August 13, 2025 Cresco refinanced its senior secured credit facility with a new US$325 million term loan (approximately C$452 million) replacing a prior US$360 million facility (approximately C$502 million).

Bennett Jones LLP acts as Canadian legal counsel to Cresco, while Mintz LLP advises Haywood Securities Inc.